SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 84.61 |
| Enterprise Value ($M) | 2.34 |
| Book Value ($M) | 96.25 |
| Book Value / Share | 1.79 |
| Price / Book | 0.88 |
| NCAV ($M) | 68.70 |
| NCAV / Share | 1.27 |
| Price / NCAV | 1.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.23 |
| Return on Assets (ROA) | 0.21 |
| Return on Equity (ROE) | 0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.35 |
| Current Ratio | 3.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 140.15 |
| Assets | 167.70 |
| Liabilities | 71.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 103.78 |
| Operating Income | 26.79 |
| Net Income | 22.81 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -32.99 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.22 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Anson Funds Management LP | 8.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 61,223 | 33,816 | 181.05 | |
| 26,144 | 70,089 | 37.30 | |
| 37,513 | 249,503 | 15.04 | |
| 17,882 | 100,011 | 17.88 | |
| 9,623 | 48,137 | 19.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SNDX – Syndax Pharmaceuticals, Inc. | SOPH – SOPHiA GENETICS SA |
| SPRB – Spruce Biosciences, Inc. | SRPT – Sarepta Therapeutics, Inc. |
| SRRK – Scholar Rock Holding Corporation |
Financial data and stock pages provided by
Fintel.io